KBL Merger Corp. IV (KBLM)
Stock Price:
$10.93 USD
0.06 (0.55%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
48.36M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-540,306 |
| Shares Out |
5.07M |
| EPS (ttm) |
-0.13 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 14, 2020 |
| Last Price |
$10.93 |
| Previous Close |
$10.87 |
| Change ($) |
0.06 |
| Change (%) |
0.55% |
| Day's Open |
10.90 |
| Day's Range |
10.90 - 10.94 |
| Day's Volume |
887 |
| 52-Week Range |
9.43 - 11.50 |
More Stats
| Market Cap |
48.36M |
| Enterprise Value |
48.44M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
5.07M |
| Float |
909,278 |
| EPS (basic) |
-0.13 |
| EPS (diluted) |
-0.13 |
| FCF / Share |
-0.30 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1,706 |
| Short Ratio |
0.06 |
| Short % of Float |
0.19% |
| Beta |
0.20 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
9.47 |
| Revenue |
n/a |
| Operating Income |
-1.19M |
| Net Income |
-540,306 |
| Free Cash Flow |
-1.35M |
| Net Cash |
-87,784 |
| Net Cash / Share |
-0.02 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-1.89% |
| ROE |
-10.81% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | - | - | - |
| Operating Income | -1.21 | -0.60 | -0.34 |
| Net Income | -0.09 | 1.04 | 0.12 |
| Shares Outstanding | 4.22 | 4.17 | 3.45 |
| Earnings Per Share | -0.02 | 0.07 | 0.01 |
| EPS Growth | - | 600% | - |
| Operating Cash Flow | -1.45 | -0.79 | -0.50 |
| Free Cash Flow | -1.45 | -0.79 | -0.50 |
| Cash & Equivalents | 0.55 | 0.27 | 0.43 |
| Total Debt | 0.37 | - | - |
| Net Cash / Debt | 0.18 | 0.27 | 0.43 |
| Assets | 12.50 | 118 | 117 |
| Liabilities | 7.15 | 4.57 | 4.23 |
| Book Value | 5.00 | 5.00 | 5.00 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
KBL Merger Corp. IV |
| Country |
United States |
| CEO |
Marlene R. Krauss |
Stock Information
| Ticker Symbol |
KBLM |
| Stock Exchange |
NASDAQ |
| Sector |
Financial Services |
| Industry |
Shell Companies |
| Unique Identifier |
NASDAQ: KBLM |
| IPO Date |
June 2, 2017 |
Description
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.